Expert Advisory Group on Government Science and Technology
Jeff Kinder has over twenty-five years of experience in government science and in science and technology (S&T) policy in the US and Canada. His experience in the US includes work at the National Science Foundation, the National Academies’ Committee on Science, Engineering and Public Policy, and research in applied ocean acoustics at the Naval Research Laboratory.
In Canada, Jeff has worked as senior policy advisor in science and innovation at Industry Canada and in support of the Council of Science and Technology Advisors (CSTA), the external board that advised Cabinet on the management of federal S&T from 1998-2006. With the CSTA, Jeff was integrally involved in producing a series of reports known by their acronyms (the SAGE, BEST, READ, STEPS, EDGE, SCOPE, LINKS and FOCUS reports) and held the pen on the Government of Canada’s Framework for Science and Technology Advice adopted by Cabinet in 2000.
In 2008, he joined Natural Resources Canada where he leads the Office of the Chief Scientist. He is currently on a special assignment supporting an external panel that is providing advice on the future of government science.
Jeff’s research and teaching focuses on S&T policy, government laboratories, innovation systems and the integration of science and policy. He is the author of Government Science 2020: Re-thinking Public Science in a Networked Age and the co-author with Bruce Doern of Strategic Science in the Public Interest: Canada’s Government Laboratories and Science-Based Agencies (University of Toronto Press, 2007). He is currently co-editor with Paul Dufour on a history of the Science Council of Canada.
Jeff helped to launch the Canadian Science Policy Conference and served on its organizing committee from 2009-2012. Jeff is a Fellow of the Institute for Science, Society and Policy (ISSP) at the University of Ottawa and a guest instructor at the Institute on Governance (IOG) in Ottawa. He holds a PhD in public policy, a Master’s in science, technology and public policy, and a BS is physics.
Associate Director Commercialization at McGill University
With over 25 years experience in the pharmaceutical, medical devices and biotechnology industry sectors, Michèle Beaulieu possesses a depth of understanding of the opportunities and issues in the healthcare market. Dr. Beaulieu holds a Ph.D. in Physiology with a specialization in Endocrinology as well as a Masters of Business Administration and has post-doctoral training in Neurosciences and Biochemical Pharmacology. Her career has covered basic medical research in Canadian and American universities followed by management, business development and executive positions in marketing in the healthcare industry in multinational and biotech companies. Dr. Beaulieu is currently Associate Director Commercialization in the Office of Sponsored Research at McGill University and has been at McGill for the past 7 years. She is also founding President of MBA Consultants, a marketing consulting firm specializing in health technologies, member of the Expert Conseil Group at Campus des technologies de la santé (CTS) and a member of the Board of Laurent Pharmaceuticals.
Director & Founder, District 3 Innovation Center at Concordia University
Xavier-Henri Hervé is a senior leader and mentor with 25 years results-oriented track record for transforming B2B strategic plans for innovations into sales and execution on an international scale. With recognized business acumen, Hervé enjoys a worldwide network built via in-situ business transactions in over fifty countries in Europe, Middle-East and Africa (EMEA), the Americas at large, and the Asian markets, with notably great success in China. Strong leadership and clear communication allows him the building of highly motivated and committed teams, all for driving complex business transformations and the alignments mandatory for innovations. An engineer, Hervé leverages 20 years of experience in several technology and engineering intensive domains such as aviation, information systems, simulation and greentech, at Mechtronix, Oracle Corporation, CAE Electronics and Bombardier. In 2012 he became the Director & Founder of District 3 Innovation Center, an ecosystem which connects technically trained, initiative taking students with alumni “entrepreneurs” to leverage multi-disciplinary skills, knowledge and tools available across Concordia’s faculties to conceive, design and engineer new products
Acting President and Program Director
Janet is currently the Acting President and a Program Director at the Council of Canadian Academies.
Prior to joining the Council, Janet served as Executive Director of the Federal Healthcare Partnership Secretariat in the Department of Veterans Affairs. Previous to that, she worked for six years in the Department of Public Safety where she was responsible for emergency preparedness and recovery. Before joining the Government of Canada, Janet worked in various capacities in the Government of Ontario, including the positions of Executive Secretary of the Ontario Quebec Permanent Commission, as a senior representative for Ontario in Brussels, as a special advisor to develop an overseas higher education marketing strategy for the Ministry of Colleges and Universities, and as a director in the Ontario Women’s Directorate.
Janet’s substantial career in the federal public service also included positions in the Department of Foreign Affairs, as Director of the Academic Relations Division, and as Consul, Cultural Affairs in New York; in Environment Canada on policy development, climate change and federal/provincial and territorial relations; in Heritage Canada as communications advisor to the minister; and at the Millennium Bureau.
Janet has a background in politics and French, having studied at the College of Europe in Belgium, the Sorbonne, the University of London and York and Trent Universities in Canada.
Special Keynote: Rosemarie Truman
Founder and CEO, The Center for Advancing Innovation, INC
Rosemarie has over 20 years of experience in driving growth for clients, having created over $21 billion in new profits for clients that launched over 100 new products/services/solutions. Her experience spans strategy consulting, investment banking, and entrepreneurship. Rosemarie has provided strategy consulting services for over 110 clients in over 15 countries and 24 states. Having started her career at Goldman Sachs as an analyst, to this day, Rosemarie’s core competencies are in complex due diligence and portfolio strategy, creating sustainable growth breakthrough strategies and transformations for clients
Currently, Ms. Truman is founder and CEO of a global public-private partnership whose mission is to accelerate and increase the volume of technology transfer, commercialization and entrepreneurship. Her firm, The Center for Advancing Innovation, has several Partnership Intermediary and collaboration agreements across the NIH. With the NIH, CDC, and the Heritage provider network, her firm is serving as managing director of a first-of-a-kind national business plan and startup Challenge for select brain focused inventions
Prior to launching her own firm, Rosemarie served as the global leader of IBM and PRTM’s Innovation and R&D strategy practice; the VP and head of global strategy at Marsh & McLennan; leader of Oracle’s Advanced Technology Group and also led eBusiness Strategy while at Ernst & Young. At IBM, Rosemarie also led internal transformation efforts in the Emerging Business Opportunity area to create models that drive sustainable “growth breakthroughs.” Finally, Rosemarie has spearheaded the development of several trade secret models, frameworks and to select and nurture sustainable growth opportunities; one model is for the Life Sciences industry called “Industry Leading R&D Performance”
Co Founder, Evidence For Democracy
Scott Findlay is Associate Professor in the Department of Biology at the University of Ottawa and a Research Scientist at the Center for Cancer Therapeutics at the Ottawa Hospital Research Institute. His main research interests concern human impacts on ecosystems, the relationship between science and policy, integration of traditional and western scientific knowledge in aboriginal community health, and the role of Darwinian evolution in cancer progression and cancer therapy. From 2003-2009, he was the Director of the Institute of the Environment at the University of Ottawa. In April 2005, he was appointed to the Science Advisory Board of the International Joint Commission, and in 2008 to the federal Challenge Advisory Panel to advise on the federal government’s Chemical Management Plan. In September 2009, he was appointed to the Expert Advisory Panel to the Commissioner of Environment and Sustainable Development. In 2011, he was commissioned by the National Judicial Institute of Canada to produce a manual for Canada’s judiciary on the interpretation of scientific evidence in the courtroom. In May 2012, he was awarded a University Chair in Teaching from the University of Ottawa, and in 2013 co-founded Evidence for Democracy, a national non-partisan organization that advocates for evidence-informed decision-making by governments.
Intellectual property and new technology: The impact of patents on innovation
Mathieu Miron, PhD
Mathieu is a patent agent registered to act before the Canadian and United States Patent Offices. Mathieu’s expertise allows him to represent clients ranging from start-up, mid-size and multi-national companies and organizations, as well as domestic and international universities. Mathieu assists clients in the drafting, prosecution and management of patent applications, prior art searches, due diligence analysis of portfolios, and the preparation of validity, infringement, or freedom-to-operate opinions.
Mathieu’s background is biochemistry, but his expertise is varied and includes inventions in the following fields: simple mechanics, medical devices, chemistry, biochemistry, pharmaceuticals and business methods.
Mathieu performed a post-doctoral fellowship at the Génome Québec and McGill University Innovation Center, where he studied DNA microarray data analysis, to then occupy a Scientific Coordinator position for the development of « FlexArray », a software tool for DNA microarray data analysis.
Mathieu started his career in intellectual property in 2007 by joining the Montréal office of Bereskin & Parr, to then joined the BENOÎT & CÔTÉ team in 2009. He became a licensed patent agent in Canada in 2011, and in the United States in 2012.
CIPO affiliate and patent agent, lawyer, and partner at GGD
Hugh Mansfield is a senior Partner at Goudreau Gage Dubuc in Montreal and has been practicing the law of patents since 2001. Prior to practicing law, Mr. Mansfield attended McGill Faculty of Engineering where he earned a BEng (Electrical) and McGill Faculty of Law where he earned both BCL and LLB degrees. He is a member of both the Quebec Bar and the Quebec Order of Engineers, and is also registered patent agent with both the Canadian Intellectual Property Office and the United States Patent and Trademark Office. In between his studies in engineering and law Mr. Mansfield developed systems and software at Elektronik System and Logistik GmbH (ESG) in Munich, Germany, primarily in support of air traffic control, and where he also acted as a representative of the German civil aviation authority on international standardization panels. Mr. Mansfield’s practice currently focusses on the preparation and prosecution of patent applications, primarily in the fields of software, electronics and telecommunications.
Partner at Bereskin & Parr LLP (moderator)
Carmela’s practice focuses on patent matters, including advising on the management of patent portfolios in Canada and abroad, the preparation and prosecution of patent applications in the life sciences and the analysis of patent issues such as validity, infringement and freedom to operate. In addition, Carmela has experience advising on regulatory compliance.
While obtaining her Ph.D. from McGill University, Carmela conducted research in the areas of inflammation, signal transduction and virology. Prior to earning a law degree from the University of Toronto, Carmela worked as a post-doctoral fellow at a research institute of an international biotechnology company where her research focused on cancer cell biology, knock-out technologies, genetic screens and genomics.
Carmela is chair of the Intellectual Property Institute of Canada’s (IPIC) Young Practitioner’s Committee. She is also the founding and present co-chair of the Greater Montreal Chapter of Women In Bio (WIB).
In addition to writing several articles on intellectual property law, Carmela has co-authored a number of peer reviewed scientific publications in journals such as Cancer Cell, Proceedings of the National Academy of Sciences, Journal of Virology, Cytokine & Growth Factor Reviews, Gene, The Journal of Biological Chemistry, Virology, Journal of Leukocyte Biology, Inflammation Research, and Advanced Experimental Medical Biology.
Carmela previously sat on the Board of Directors of the Canadian charity, Meal Exchange.
Ma’n H. Zawati,
Ma’n H. Zawati (LL.B., LL.M.) is a lawyer and the Academic Coordinator of the Centre of Genomics and Policy at McGill University. He is also an Associate Member of the Biomedical Ethics Unit at McGill University. His research focuses on the legal and ethical aspects of biobanking as well as the legal duties and liability of health care professionals in both the clinical and research settings.
He has published numerous articles on issues such as access to genomic databases, the return of research results/incidental findings in genomic research, the legal liability of physicians and the closure of biobanks. Mr. Zawati has also presented on these topics in Canada and internationally and is a frequent guest lecturer at the University of Montreal, McGill University and the Université de Sherbrooke.
He is currently a lecturer at the University of Montreal, having taught Biological Sciences Law (DRT3802G) and Civil Liability (DRT1222G) courses. He is also Chief Tutor of the SGS Ethical Issues in Genetics (Basis of Medicine – Unit 8) at McGill University’s Faculty of Medicine. Mr. Zawati sits on the Board of Directors of the Canadian Bioethics Society, representing Eastern Canada (Quebec) and is a legal representative on the research ethics committee of the Montreal General Hospital.
In 2010, he was awarded the Erasmus Mundus Fellowship of the European Commission and was a Visiting Scholar at the Katholieke Universiteit in Leuven, Belgium in the fall semester of that year. In 2011, he was awarded the John and Edmund Day Award, the Justice K. Hugessen Fellowship and the Rathlyn Foundation Award at McGill University’s Faculty of Law, where he is completing his Doctoral degree in law (D.C.L.). In 2012, he was awarded a Doctoral Scholarship from the Fonds québécois de recherche sur la société et la culture (FQRSC).
Director, Neuroethics Research Unit at IRCM
Dr. Eric Racine is the Director of the Neuroethics Research Unit and Associate Research Professor at the IRCM (Institut de recherches cliniques de Montréal). He also holds other academic appointments at the University of Montreal and McGill University.
Dr. Racine’s research interests span a range of topics and methods with the goal of developing a pragmatic framework for bioethics based on empirical research and exploring its implications in concrete questions related to the ethical application of neuroscience in research, patient care and public policy. He is a prolific author of peer reviewed papers, chapters, and columns published in leading bioethics, neuroscience, social science, and clinical journals. He has delivered numerous talks and guest lectures to international audiences. His book Pragmatic Neuroethics, was published at MIT Press in 2010 and captures some of his work and views in neuroethics.
Dr. Racine is a New Investigator of the Canadian Institutes of Health Research (CIHR) and his research is funded by several peer reviewed bodies (e.g., Social Sciences and Humanities Research Council, CIHR).Eric Racine did his postdoctoral training in neuroethics at the Stanford Center for Biomedical Ethics under the supervision of Dr. Judy Illes and previously studied bioethics, philosophy and social science at the University of Ottawa (Summa Cum Laude) and the University of Montreal. He completed clinical ethics internships in Geneva and Montreal during his doctoral training. Dr. Racine has been a visiting fellow in fellow at the Brocher Foundation in Geneva (Switzerland), at the International Institute of Biomedical Ethics at Uppsala University (Sweden), and the Center for Advanced Studies at the University of Munich (Germany).
Dr. Racine’s research is designed to improve the ethical aspects of quality of care, research practices and public communications in the domain of clinical and basic neuroscience. Various approaches and research methods, such as qualitative interviews, content analysis and media studies, are used to develop ethical approaches in health care and research. For example, some research projects propose ethical approaches to end-of-life decision-making for patients with severe neurological conditions, while others examine and attempt to improve the quality of information available in the media on neurological conditions and research methods in neuroscience
Dr. Eric Racine is currently associate editor of the journal Neuroethics, member of the editorial board of AJOB-neuroscience, member of the advisory board of the CIHR Institute for Neurosciences, Mental Health and Addiction, and a member of the DANA Alliance for Brain Initiatives. He has been involved in the organization of seminal events in neuroethics such as the first edition of the INS annual conference and the three past editions of the Brain Matters, international neuroethics conferences in Canada and the US.
Director at Institute for Science, Society and Policy
Dr. Marc Saner is the inaugural Director of the Institute for Science, Society and Policy (since July 1, 2010), and an Associate Professor in the University of Ottawa Department of Geography.
Prior to this appointment, he served as Executive Director, Regulatory Governance Initiative, School of Public Policy and Administration, at Carleton University, and Director of Assessments and Executive Vice-President of the Council of Canadian Academies. Previously, Dr. Saner was a Director at the Institute on Governance where he built the Ethics and Risk Management Sector and co-managed the Technology and Governance Program.
For the last decade, his primary interest has been multi-disciplinary work at the intersection of science, ethics and governance. He holds a PhD in Biology from the University of Basel, Switzerland (1991) as well as an MA in Philosophy from Carleton University (1999).
Dr. Saner publishes in peer-reviewed journals in the areas of technology ethics, bioethics, risk management, biotechnology and ecology and has been invited to speak at seminars, workshops and international conferences around the world. He was also appointed Adjunct Research Professor in Philosophy at Carleton University.
Full professor; Director, Centre of Genomics and Policy
Bartha Maria Knoppers, PhD (Comparative Medical Law), holds the Canada Research Chair in Law and Medicine (Tier 1: 2001 – ). She is Director of the Centre of Genomics and Policy, Faculty of Medicine, Department of Human Genetics, McGill University. She holds four Doctorates Honoris Causa, is Fellow of: the AAAS, the Hastings Center (Bioethics) and the Canadian Academy of Health Sciences (CAHS) as well as Officer of the Order of Canada and of Quebec. She received the “Prix Montreal In Vivo: Secteur des sciences de la vie et des technologies de la santé” in 2012 and in 2013 was named “Champion of Genetics” by the Canadian Gene Cure Foundation.
Manager External Communications & Philanthropy at L’Oréal Canada. “L’Oréal-UNESCO For Women on Science : Changing the face of science”
Ms. Virginie Hotte?Dupuis is Manager of External Communications & Philanthropy at L’Oréal Canada since 2007. With a career spanning nearly 20 years in the cosmetics industry, Ms. Hotte?Dupuis began her career as a beauty expert for a major Canadian drugstore chain where she learned (almost) all the trade secrets of the beauty and personal care industry! She joined L’Oréal Canada in 2001 as a Trainer and PR specialist for the Active Cosmetics Division and its dermo?cosmetics brands such as Vichy and La Roche?Posay, two of the most recommended brands by Canadian dermatologists. She then moved on to the L’Oréal Luxe division as a Communications Manager for the Biotherm brand, where she was responsible for managing the PR campaign around the brand’s first North American spokesperson, actor Chris Noth. She joined the L’Oréal Canada Corporate Communications team in 2007. Her main responsibilities are to highlight L’Oréal Canada’s best practices, and develop the L’Oréal Foundation’s international philanthropic programs such as L’Oréal?UNESCO For Women and Science and Look Good Feel Better in Canada. Ms. Hotte?Dupuis studied Communications at the Université de Montréal, where she obtained a BA in Communications and a Major in English Studies. She is a mother of two and in her (very little!) spare time she enjoys reading novels, going to the movies and tap dancing.
Structural stress engineer at Bombardier Aerospace
Jean-Claude Bastien started as a Mechanical Engineer in the Pulp-and-Paper, Hydro-electric & Nuclear fields for his first 5 years, concentrating mainly in Co-generation and Combined Cycles plant energy optimization. Jean-Claude Bastien completed a Masters of Aerospace at Concordia University in 1997 and is presently working (as of 20 years) at Bombardier Aerospace as an Airframe Structural Stress Engineer Specialist. He has contributed to Bombardier Aerospace’s structural optimization and communication.
> also available in French